This study investigates advanced solid tumors.
The study evaluates the safety of an investigational medication for participants with advanced solid tumors. It investigates how the medication interacts with the body and its potential effects on these types of tumors.
- Who can participate: Participants must be adults with metastatic or unresectable solid tumor malignancies and have relapsed or progressive disease with no appropriate standard therapy available.
- Study details: Participants will receive an investigational medication to study its effects on advanced solid tumors. A placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine, may be used for comparison in some parts of the study.
How understandable was the trial content above?
Hard to understand
Easy to understand